共 170 条
[1]
Bellmunt J(2009)Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 79-80
[2]
Albiol S(2000)Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 3068-3077
[3]
Kataja V(2005)Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 4602-4608
[4]
von der Maase MH(1989)Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse Cancer 64 2448-2458
[5]
Hansen SW(1992)A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 10 1066-1073
[6]
Roberts JT(1996)Synergistic interaction between cisplatin and gemcitabine in vitro Clin Cancer Res 2 521-530
[7]
Dogliotti L(2006)Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma J Clin Pathol 59 1254-1260
[8]
Oliver T(2000)Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group J Clin Oncol 18 3247-3255
[9]
Moore MJ(2000)Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules Cancer 88 1671-1678
[10]
Bodrogi I(2000)New approaches to treatment of metastatic bladder cancer Curr Oncol Rep 2 379-385